Bionpharma Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
3
- Investments
-
6
Bionpharma General Information
Description
Developer of complex generic pharmaceuticals intended to commercialize affordable quality generics and build strong and effective partnerships. The company develops and distributes generic pharmaceutical products and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution and supply chain management, enabling clients to get soft gel capsules in the US market.
Contact Information
Website
www.bionpharma.comCorporate Office
- Suite #2-4B
- 400 Alexander Park
- Princeton, NJ 08540
- United States
Corporate Office
- Suite #2-4B
- 400 Alexander Park
- Princeton, NJ 08540
- United States
Bionpharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionpharma Patents
Bionpharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180071221-A1 | Immediate release soluble ibuprofen compositions | Inactive | 02-Mar-2015 | ||
| US-8309107-B2 | Stable solutions of orlistat for pharmaceutical dosage forms | Inactive | 06-Oct-2008 | ||
| US-20100087520-A1 | Stable solutions of orlistat for pharmaceutical dosage forms | Active | 06-Oct-2008 | ||
| US-6251426-B1 | Ibuprofen-containing softgels | Inactive | 02-Sep-1999 | A61K31/192 |
Bionpharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bionpharma Investments (6)
Bionpharma’s most recent deal was a Buyout/LBO with Pharma Nobis for . The deal was made on 04-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pharma Nobis | 04-Feb-2022 | Buyout/LBO | Pharmaceuticals | ||
| Fagron (Texarkana) | 01-Feb-2022 | Buyout/LBO | BPO/Outsource Services | ||
| OrBion Pharmaceuticals | 19-Sep-2021 | Buyout/LBO | Pharmaceuticals | ||
| Nuwill Research and Innovations | 01-Jan-2020 | Buyout/LBO | Pharmaceuticals | ||
| CoreRx | 01-Jan-2017 | Corporate | BPO/Outsource Services |
Bionpharma Exits (1)
Bionpharma’s most recent exit was on 01-Jan-2017 from CoreRx. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CoreRx | 01-Jan-2017 | Completed |
|
Bionpharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nuwill Research and Innovations | Bangalore, India | ||
| OrBion Pharmaceuticals | Chennai, India |
Bionpharma FAQs
-
When was Bionpharma founded?
Bionpharma was founded in 2014.
-
Where is Bionpharma headquartered?
Bionpharma is headquartered in Princeton, NJ.
-
What industry is Bionpharma in?
Bionpharma’s primary industry is Pharmaceuticals.
-
Is Bionpharma a private or public company?
Bionpharma is a Private company.
-
What is Bionpharma’s current revenue?
The current revenue for Bionpharma is .
-
How much funding has Bionpharma raised over time?
Bionpharma has raised $37.2M.
-
Who are Bionpharma’s investors?
Athyrium Capital Management, Pharmascience, and Signet Healthcare Partners have invested in Bionpharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
